Post Operative Nausea And Vomiting - Pipeline Review, H2 Pharmaceutical 2016
"Post
Operative Nausea And Vomiting - Pipeline Review, H2 2016"
The Report covers current Market Trends, Worldwide Analysis, Global
Forecast, Review, Share, Size, Growth, Effect.
Description-
Global
Markets Direct's latest Pharmaceutical and Healthcare disease
pipeline guide Post Operative Nausea And Vomiting - Pipeline Review,
H2 2016, provides an overview of the Post Operative Nausea And
Vomiting (Gastrointestinal) pipeline landscape.
Postoperative
nausea and vomiting (PONV) is one of the commonest complaints
following anaesthesia, and can result in morbidity like wound
dehiscence, bleeding, pulmonary aspiration of gastric contents, fluid
and electrolyte disturbances, delayed hospital discharge, unexpected
hospital admission, and decreased patient satisfaction. The thorough
understanding of the mechanism of nausea and vomiting and a careful
assessment of risk factors provide a rationale for appropriate
management of PONV. This multimodal PONV management approach includes
use of: (i) multiple different antiemetic medications (double or
triple combination antiemetic therapy acting at different
neuroreceptor sites); (ii) less emetogenic anaesthesia techniques;
(iii) adequate intravenous hydration; and (iv) adequate pain control.
Report
Highlights
Global
Markets Direct's Pharmaceutical and Healthcare latest pipeline guide
Post Operative Nausea And Vomiting - Pipeline Review, H2 2016,
provides comprehensive information on the therapeutics under
development for Post Operative Nausea And Vomiting
(Gastrointestinal), complete with analysis by stage of development,
drug target, mechanism of action (MoA), route of administration (RoA)
and molecule type. The guide covers the descriptive pharmacological
action of the therapeutics, its complete research and development
history and latest news and press releases.
The
Post Operative Nausea And Vomiting (Gastrointestinal) pipeline guide
also reviews of key players involved in therapeutic development for
Post Operative Nausea And Vomiting and features dormant and
discontinued projects. The guide covers therapeutics under
Development by Companies /Universities /Institutes, the molecules
developed by Companies in Phase III, Phase II, Phase I and Unknown
stages are 2, 1, 1 and 1 respectively.Post Operative Nausea And
Vomiting.
Scope
-
The pipeline guide provides a snapshot of the global therapeutic
landscape of Post Operative Nausea And Vomiting (Gastrointestinal).
-
The pipeline guide reviews pipeline therapeutics for Post Operative
Nausea And Vomiting (Gastrointestinal) by companies and
universities/research institutes based on information derived from
company and industry-specific sources.
-
The pipeline guide covers pipeline products based on several stages
of development ranging from pre-registration till discovery and
undisclosed stages.
-
The pipeline guide features descriptive drug profiles for the
pipeline products which comprise, product description, descriptive
licensing and collaboration details, R&D brief, MoA & other
developmental activities.
-
The pipeline guide reviews key companies involved in Post Operative
Nausea And Vomiting (Gastrointestinal) therapeutics and enlists all
their major and minor projects.
Reasons
to buy
-
Procure strategically important competitor information, analysis, and
insights to formulate effective R&D strategies.
-
Recognize emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive
advantage.
-
Find and recognize significant and varied types of therapeutics under
development for Post Operative Nausea And Vomiting
(Gastrointestinal).
-
Classify potential new clients or partners in the target demographic.
-
Develop tactical initiatives by understanding the focus areas of
leading companies.
-
Plan mergers and acquisitions meritoriously by identifying key
players and its most promising pipeline therapeutics.
-
Formulate corrective measures for pipeline projects by understanding
Post Operative Nausea And Vomiting (Gastrointestinal) pipeline depth
and focus of Indication therapeutics.
Comments
Post a Comment